Shamith Samarajiwa
Cited by
Cited by
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
Type I interferon receptors: biochemistry and biological functions
NA De Weerd, SA Samarajiwa, PJ Hertzog
Journal of Biological Chemistry 282 (28), 20053-20057, 2007
Spatial coupling of mTOR and autophagy augments secretory phenotypes
M Narita, ARJ Young, S Arakawa, SA Samarajiwa, T Nakashima, ...
Science 332 (6032), 966-70, 2011
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
BN Bidwell, CY Slaney, NP Withana, S Forster, Y Cao, S Loi, D Andrews, ...
Nature Medicine, 2012
A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data
NL Barbosa-Morais, MJ Dunning, SA Samarajiwa, JFJ Darot, ME Ritchie, ...
Nucleic acids research 38 (3), e17-e17, 2010
INTERFEROME: the database of interferon regulated genes
SA Samarajiwa, S Forster, K Auchettl, PJ Hertzog
Nucleic acids research 37 (suppl_1), D852-D857, 2009
Independence of Repressive Histone Marks and Chromatin Compaction during Senescent Heterochromatic Layer Formation
T Chandra, K Kirschner, JY Thuret, BD Pope, T Ryba, S Newman, ...
Molecular Cell, 2012
Systems biology of interferon responses
P Hertzog, S Forster, S Samarajiwa
Journal of Interferon & Cytokine Research 31 (1), 5-11, 2011
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production
AN Harman, J Lai, S Turville, S Samarajiwa, L Gray, V Marsden, ...
Blood, The Journal of the American Society of Hematology 118 (2), 298-308, 2011
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium
DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ...
EMBO molecular medicine 3 (3), 167-180, 2011
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.
KVN Vollan HK, Rueda OM, Chin SF, Curtis C, Turashvili G, Shah S, Lingjćrde ...
Mol Oncol., 2015
Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.
MCP Turrell FK, Kerr EM, Gao M, Thorpe H, Doherty GJ, Cridge J, Shorthouse D ...
Genes Dev., 2017
NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence
AJ Parry, M Hoare, D Bihary, R Hänsel-Hertsch, S Smith, K Tomimatsu, ...
Nature communications 9 (1), 1-15, 2018
Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53.
Kirschner K, Samarajiwa SA, Cairns JM, Menon S, Pérez-Mancera PA, Tomimatsu ...
PLoS Genet. 11 (3), 2015
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma
SE Syafruddin, P Rodrigues, E Vojtasova, SA Patel, MN Zaini, J Burge, ...
Nature communications 10 (1), 1-13, 2019
Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock.
SA Samarajiwa, NE Mangan, MP Hardy, ...
J Immunol, 2014
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
AT Maia, AC Antoniou, M O'Reilly, S Samarajiwa, M Dunning, ...
Breast cancer research 14 (2), 1-15, 2012
NF-κB–dependent lymphoid enhancer co-option promotes renal carcinoma metastasis
P Rodrigues, SA Patel, L Harewood, I Olan, E Vojtasova, SE Syafruddin, ...
Cancer discovery 8 (7), 850-865, 2018
Type I interferons: genetics and structure
SA Samarajiwa, W Wilson, PJ Hertzog
Characterization and Application: The Interferons, 2006
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
Z Hu, JH Mao, C Curtis, G Huang, S Gu, L Heiser, ME Lenburg, ...
Breast cancer research 18 (1), 1-12, 2016
The system can't perform the operation now. Try again later.
Articles 1–20